Evidence map›Paper›PMID 38152826›Full record

ArticleCureus2023

Mixed High-Risk Endometrial Carcinoma Initially Presented With Atypical Squamous Cells of Undetermined Significance (ASC-US) Cytology: Lessons to Be Learned.

Chrysoula Margioula-Siarkou, Emmanouela-Aliki A Almperi, Aristarchos Almperis, Konstantinos Dinas, Stamatios Petousis

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chrysoula Margioula-Siarkou2nd Department of Obstetrics and Gynaecology, Gynaecologic Oncology Unit, Ippokrateio General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Emmanouela-Aliki A Almperi2nd Department of Obstetrics and Gynaecology, Gynaecologic Oncology Unit,, Ippokrateio General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Aristarchos Almperis2nd Department of Obstetrics and Gynaecology, Gynaecologic Oncology Unit, Ippokrateio General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Konstantinos Dinas2nd Department of Obstetrics and Gynaecology, Gynaecologic Oncology Unit, Ippokrateio General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Stamatios Petousis2nd Department of Obstetrics and Gynaecology, Gynaecologic Oncology Unit, Ippokrateio General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Aristotle University of Thessaloniki · GRIppokrateio General Hospital of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial carcinoma represents the most common gynecologic malignancy, affecting mainly postmenopausal women. Early detection and proper management may allow not only a successful treatment but also an acceptable quality of life. Although its usual clinical manifestations, such as vaginal bleeding or a mass stuck out of the cervix, often arouse medical concern, in some cases, there is a dilemma regarding the differential diagnosis of endocervical cancer. Additionally, tumors arising from and confined to the uterine isthmus may often pose a greater diagnostic challenge. Defining the primary origin of the carcinoma is of paramount importance as the treatment plan may be widely different in these two scenarios. Magnetic Resonance Imaging (MRI), markers, and biopsy with immunohistochemistry could facilitate the diagnostic process, but the final diagnosis may even be made from the final surgical specimen in such demanding cases. We present the case of a mixed-type, stage IIIC2, endometrial carcinoma arising from the lower uterine segment initially suspected from atypical squamous cells of undetermined significance (ASC-US) cytology.

Indexed as

cervical cancercytologyendometrial cancerimmunohistochemistrylymphadenectomy

Identifiers

PMID38152826
PMCPMC10751426
OpenAlexW4389054708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.